Autophagy inhibition exerts neuroprotection on white matter ischemic damage after chronic cerebral hypoperfusion in mice

Brain Res. 2019 Oct 15:1721:146337. doi: 10.1016/j.brainres.2019.146337. Epub 2019 Jul 15.

Abstract

Autophagy plays vital roles in the pathophysiology of many central nervous system diseases. Emerging evidence indicates that autophagy has both detrimental and protective effects in ischemic cerebral injury. This study aimed to investigate the temporal pattern of autophagy activation in the white matter of bilateral common carotid artery stenosis (BCAS) mouse model by immunofluorescence and western blotting. The effect of wortmannin, an autophagy inhibitor, against hypoperfusion induced white matter injury (WMI) was studied by immunofluorescence and eight-arm radial maze test. We found that autophagy was initially activated in the white matter 3 days after BCAS, and then suppressed by day 10, and was activated again at day 30. Administration of wortmannin during the first three days after BCAS revealed protective effects on axon-glia integrity and against the cognitive injury induced by the chronic hypoperfusion. The results indicated the possible link between autophagy and white matter ischemic damage after chronic cerebral hypoperfusion. Modulation of autophagy in a time course dependent manner may broaden the insight on the treatment of WMI.

Keywords: Autophagy; Axon-glia integrity; White matter injury.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Autophagy / physiology*
  • Axons / drug effects
  • Brain Ischemia / metabolism
  • Brain Ischemia / physiopathology
  • Carotid Stenosis / metabolism
  • Carotid Stenosis / physiopathology*
  • Disease Models, Animal
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Microglia / drug effects
  • Neuroglia / drug effects
  • Neuroprotective Agents
  • White Matter / physiopathology*
  • Wortmannin / pharmacology

Substances

  • Neuroprotective Agents
  • Wortmannin